The company is one of the leading players in the interventional cardiology market with its coronary stent product offerings. Boston Scientific markets a broad portfolio of internally-developed and ...

The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

at 1 millimeter less than the perimeter-derived diameter,” Boston Scientific’s chief medical officer for interventional cardiology therapies, Janar Sathananthan, M.D., said in an interview.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional ... segment consists of Cardiology and Peripheral Interventions.

Boston Scientific reported 29.2% growth for cardiology products and 11.8% growth in peripheral interventions. MedSurg segment revenues increased 10.3% to $1.48 billion (10.4% operationally and 7.7 ...

Boston Scientific has proven itself to be a ... neuromodulation, and other interventional cardiology and interventional oncology devices. With specialists demonstrating preference for certain ...

Boston Scientific has solidified its footing ... neuromodulation, and other interventional cardiology and interventional oncology devices. With specialists demonstrating preference for certain ...